Yves Bonhomme
Directeur/Membre du Conseil chez Bellus Health (Innodia), Inc.
Profil
Yves Bonhomme is a Director of Innodia, Inc. Prior to joining Innodia, he was Managing Director and Head of Research and Development for Lipha SA until 2002 and Chairman of Lyon University School of Pharmacy from 1997 to 2001.
Dr. Bonhomme has diabetes research and product development experience.
He received an undergraduate degree from INSEAD.
Postes actifs de Yves Bonhomme
| Sociétés | Poste | Début |
|---|---|---|
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yves Bonhomme
| Sociétés | Poste | Fin |
|---|---|---|
| University of Lyon | Corporate Officer/Principal | 01/01/2001 |
Formation de Yves Bonhomme
| INSEAD | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |